42824 Federal Register / Vol. 82, No. 175 / Tuesday, September 12, 2017 / Notices 

high affinity for plasma albumin and 

has been used for a long time in clinical 

practice for determination of patient 

plasma volume. The current imaging 

agent is a truncated form of EB [NEB]) 

and has the ability to bind albumin with 

high affinity. The agent is also 

conjugated to NOTA to enable in vivo 

labeling with 18F labeling by the 

formation of 18F-aluminum fluoride 

complex. The NOTA also facilitates 

radiometal labeling of NEB with either 

68Ga or 64Cu. The resulting imaging 

agent does not affect the in vivo 

behavior of serum albumin such as 

circulation, extra-vascularization, and 

turn-over; thus the imaging results will 

reflect the distribution and metabolism 

of serum albumin accurately. 

Potential Commercial Applications: 

• Blood pool imaging. 

• Lymphatic system imaging. 

Development Stage: 

• In vivo data available. 

Inventors: Xiaoyuan Chen, Lixin Lang, 

Gang Niu (all of NIBIB). 

Intellectual Property: HHS Reference 

No. E–099–2015/0–US–01 and/0–US– 

02. 

• U.S. Patent Applications 

14/675,364 filed March 31, 2015 and 

15/587,948 filed May 5, 2017. 

Licensing Contact: Michael 

Shmilovich, Esq, CLP; 301–435–5019; 

shmilovm@nih.gov. 

Collaborative Research Opportunity: 

The National Institute of Environmental 

Health Sciences seeks statements of 

capability or interest from parties 

interested in collaborative research to 

further develop and evaluate, please 

contact Cecilia Pazman, Office of 

Technology Transfer, National Heart, 

Lung and Blood Institute, pazmance@

nhlbi.nih.gov, 301–594–4273. 

Dated: September 7, 2017. 

Michael Shmilovich, 

Senior Licensing and Patenting Manager, 

National Heart, Lung, and Blood Institute, 

Office of Technology Transfer and 

Development. 

[FR Doc. 2017–19313 Filed 9–11–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Shared 

Instrumentation Grants for Flow Cytometers. 

Date: September 26, 2017. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Jonathan Arias, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5170, 

MSC 7840, Bethesda, MD 20892, 301–435– 

2406, ariasj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Shared and 

High-End Mass Spectrometers. 

Date: September 28–29, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Sudha Veeraraghavan, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–435–1504, 

sudha.veeraraghavan@nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Nursing and Related Clinical Sciences Study 

Section. 

Date: October 2–3, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Rafael Semansky, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2040M, 

Bethesda, MD 20892, 301–496–5749, 

semanskyrm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Clinical 

Studies in Kidney Diseases (PAR–15–161). 

Date: October 2, 2017. 

Time: 2:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Atul Sahai, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2188, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1198, sahaia@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 6, 2017. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–19230 Filed 9–11–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Resource 

Centers for Minority Aging Research 

(RCMAR) ZAG1 ZIJ–9 J1. 

Date: October 31–November 1, 2017. 

Time: 5:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, Bethesda, MD 20814. 

Contact Person: Carmen Moten, Ph.D., 

MPH, Scientific Review Officer, National 

Institute on Aging, Gateway Building, 7201 

Wisconsin Avenue, Suite 2C212, Bethesda, 

MD 20892, 301–402–7703, cmoten@

mail.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Resource 

Centers for Minority Aging Research 

(RCMAR) ZAG1 ZIJ–9 J3. 

Date: October 31–November 1, 2017. 

Time: 5:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, Bethesda, MD 20814. 

Contact Person: Carmen Moten, Ph.D., 

MPH, Scientific Review Officer, National 

Institute on Aging, Gateway Building, 7201 

Wisconsin Avenue, Suite 2C212, Bethesda, 

MD 20892, 301–402–7703, cmoten@

mail.nih.gov. 


pmangrum on DSK3GDR082PROD with NOTICES1